I suspect that probably means when our first patient is likely to be dosed? To get to that point, PYC would now be locking in sites and once that step is completed I would expect patient enrolment which then leads to dosing?
So in a way, we may both be correct, the difference maybe in the detail?
I'm sticking to we are starting right away, and it would seem to fit for patient dosing to commence in April?
Ann: Approval to Commence Human Trials in Kidney Program, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $45.30K | 38.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |